1,755 results on '"Besra, Gurdyal S."'
Search Results
2. The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth
3. Structural analysis of phosphoribosyltransferase-mediated cell wall precursor synthesis in Mycobacterium tuberculosis
4. A structural perspective of how T cell receptors recognize the CD1 family of lipid antigen–presenting molecules
5. Top five unanswered questions in bacterial cell wall research
6. DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
7. Sensitive lipid biomarker detection for tuberculosis in late Neanderthal skeletons from Subalyuk Cave, Hungary
8. Professor David Minnikin Memorial Lecture: An era of the mycobacterial cell wall lipid biomarkers
9. Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis
10. The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation
11. Biochemical and phenotypic characterisation of the Mycobacterium smegmatis transporter UspABC
12. Evasion of MAIT cell recognition by the African Salmonella Typhimurium ST313 pathovar that causes invasive disease
13. Ligand-dependent downregulation of MR1 cell surface expression
14. Synthesis and recycling of the mycobacterial cell envelope
15. Chemical insights into the search for MAIT cells activators
16. 362 Allelic variants of MR1 drive cancer and allo-reactivity by MR1-restricted T cells
17. Cryo-EM snapshots of mycobacterial arabinosyltransferase complex EmbB2-AcpM2
18. Targeting mitochondrial dysfunction in MAIT cells limits IL-17 production in obesity
19. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones
20. The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth
21. Differing roles of CD1d2 and CD1d1 proteins in type I natural killer T cell development and function
22. Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties
23. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone
24. Modulation of CD1d-Restricted NKT Cell Responses by Using N-Acyl Variants of α-Galactosylceramides
25. CD1d-Restricted T Cell Activation by Nonlipidic Small Molecules
26. The T Cell Antigen Receptor Expressed by Vα14i NKT Cells Has a Unique Mode of Glycosphingolipid Antigen Recognition
27. Structural determination of lipid antigens captured at the CD1d–T-cell receptor interface
28. Conserved allomorphs of MR1 drive specificity of MR1-restricted TCRs
29. Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses
30. The DprE1 Inhibitors: Enduring aspirations for future Anti‐TB Drug Discovery
31. Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
32. Fluorescent mannosides serve as acceptor substrates for glycosyltransferase and sugar-1-phosphate transferase activities in Euglena gracilis membranes
33. Nuclear-Encoded Proteins Target to the Plastid in Toxoplasma gondii and Plasmodium falciparum
34. Supplementary Figure 3 from β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy
35. Supplementary Figure 2 from β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy
36. Supplementary Figure 1 from β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy
37. Supplementary Figure 3 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
38. Supplementary Legends 1-5, Table 1, Methods from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
39. Supplementary Figure 4 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
40. Supplementary Figure 5 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
41. Supplementary Figure 1 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
42. Supplementary Figure 2 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
43. The embAB Genes of Mycobacterium avium Encode an Arabinosyl Transferase Involved in Cell Wall Arabinan Biosynthesis that is the Target for the Antimycobacterial Drug Ethambutol
44. Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T-cells
45. The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells
46. Human autoreactive T cells recognize CD1b and phospholipids
47. The hydrolase LpqI primes mycobacterial peptidoglycan recycling
48. DprE1 Inhibitors: Enduring Aspirations for Future Antituberculosis Drug Discovery.
49. Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition
50. Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.